- Bon Natural Life Ltd BON has developed new nutraceutical compounds, Glucoraphanin (GF) and Sulforaphane (SFN), extracted from cruciferous vegetables.
- The compounds could provide immunity support and improve certain regulatory health functions.
- The company plans to launch GF and SFN-based consumer products, including immune system boosters, digestive boosters, sleep aid products, and weight loss products, in the next six months.
- The products will be launched through multiple sales channels, including direct sales to pharmacies and enterprise clients, e-commerce platforms, and distributors.
- Price Action: BON shares are trading higher by 4.57% at $3.66 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
